We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.083 | -5.78% | 1.352 | 1.352 | 1.598 | 1.352 | 1.352 | 1.35 | 64,639 | 08:30:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0050 | -2.86 | 19.26M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/4/2024 06:42 | How are your 2.3p PPP shares doing purple11?....... LOL Simples!........ :-) | nigoil | |
25/4/2024 06:27 | Lots of admin expenses | countbasie1 | |
25/4/2024 06:12 | Unfortunately this is screwed as an investment. They have pal but admitted more funding will be required over and over again.. Death spiral finance will wipe out shareholders value here. Possible end up going private once they have milked what they can out of shareholders. Sad state of affairs for most small cap companies now. Don't life in hope relaity is death spiral | bones698 | |
24/4/2024 09:04 | like a lion sitting by the oasis waiting for a mug punter working capitol feeling parched. | dreamtwister | |
23/4/2024 08:08 | looking for a move to 2.5-4p an explosive move on good news the science continues.. | purple11 | |
23/4/2024 07:29 | How's your 2.3p PPP shares doing purple11?.....LOL Simples!.......;-) | nigoil | |
23/4/2024 07:01 | 122856 my BUY@1.615 Will add twice more higher or lower gl | purple11 | |
22/4/2024 21:47 | hemo often pushes the price up to 4p on good news i expect another go 2 1/2p a nice trade for a thousand buying at 1.5p always pays off in hemo | purple11 | |
22/4/2024 21:29 | yes i will ofcourse | purple11 | |
22/4/2024 21:23 | Being so candid, Purple, I assume you'll be posting your 'Buy' on here when you do tomorrow. When you don't, please expect nothing less than what you deserve... | bahamarama | |
22/4/2024 20:49 | this is the kinda price i was hoping to buy at so i will in the morning. good luck everyone. | purple11 | |
12/4/2024 10:39 | By tempted back in below 1.4 | trying2trade | |
12/4/2024 08:59 | biodefence still rumbling. This issue may be on going so this gives Dr Sandler the opportunity to implement a alternative supplier ? | dreamtwister | |
10/4/2024 13:28 | Doing well innit | albert35911 | |
09/4/2024 14:19 | interesting link below, custom & off the shelf car-t manufacturing pro`s & cons ? hemogenyx have chosen to go down the custom route, | dreamtwister | |
08/4/2024 19:54 | FDA accepts Shorla’s oral liquid leukemia drug NDA SH-201 is an oral liquid drug, making the treatment accessible to patients who may struggle with taking tablets or other dosage forms. It slows or stops the growth of certain forms of leukemia, including chronic myeloid leukemia and acute lymphoblastic leukemia. The blood science is becoming more accessible & cost effective.... Below the link gives a insight to the Car-t science. | dreamtwister | |
08/4/2024 08:05 | well the cd38 therapy has been approved, Dr Sandler has now to bring cd19 to the clinical trials. | dreamtwister | |
07/4/2024 18:54 | hxxps://www.biospace Hemo next? bankruptcies skyrocket in biotech !! WHO OWNS HEMO CASINO SHARES !!? | marcus80 | |
07/4/2024 17:12 | Great news ! FDA allows expanded use of cell therapies for blood cancer The drugs from Johnson & Johnson and Bristol Myers Squibb can be used to treat patients in the earlier stages of a type of blood cancer. | dreamtwister |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions